关注
Ruth E Cooper
Ruth E Cooper
未知所在单位机构
在 nhs.net 的电子邮件经过验证
标题
引用次数
引用次数
年份
The serotonin theory of depression: a systematic umbrella review of the evidence
MAH Joanna Moncrieff, Ruth E Cooper, Tom Stockmann, Simone Amendola, Michael ...
Molecular Psychiatry, 2022
658*2022
Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial
RE Cooper, E Williams, S Seegobin, C Tye, J Kuntsi, P Asherson
European Neuropsychopharmacology 27 (8), 795-808, 2017
1722017
Validation of the mind excessively wandering scale and the relationship of mind wandering to impairment in adult ADHD
FD Mowlem, C Skirrow, P Reid, S Maltezos, SK Nijjar, A Merwood, ...
Journal of attention disorders 23 (6), 624-634, 2019
1502019
Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis
RE Cooper, C Tye, J Kuntsi, E Vassos, P Asherson
Journal of Psychopharmacology 29 (7), 753-763, 2015
1422015
The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: A systematic review and meta …
RE Cooper, C Tye, J Kuntsi, E Vassos, P Asherson
Journal of affective disorders 190, 474-482, 2016
972016
Effects of stimulants and atomoxetine on emotional lability in adults: a systematic review and meta-analysis
TR Moukhtarian, RE Cooper, E Vassos, P Moran, P Asherson
European Psychiatry 44, 198-207, 2017
632017
Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review
RE Cooper, N Laxhman, N Crellin, J Moncrieff, S Priebe
Schizophrenia Research, 2019
542019
The effects of emotional lability, mind wandering and sleep quality on ADHD symptom severity in adults with ADHD
B Helfer, RE Cooper, N Bozhilova, S Maltezos, J Kuntsi, P Asherson
European Psychiatry 55, 45-51, 2019
452019
Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: a systematic review
J Moncrieff, NE Crellin, MA Long, RE Cooper, T Stockmann
Schizophrenia research 225, 47-54, 2020
432020
Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data.
J Thompson, J., Stansfield, J., Cooper, R.E., Morant, N., Crellin, N., Moncrieff
Social Psychiatry and Psychiatric Epidemiology., 2019
39*2019
Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation
RE Cooper, E Hanratty, N Morant, J Moncrieff
PLOS ONE 14 (6), 1-18, 2019
362019
Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into …
SP Joanna Moncrieff, Glyn Lewis, Nick Freemantle, Sonia Johnson, Thomas R E ...
BMJ Open, 2019
352019
An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders
J Crellin, NE., Priebe, Morant, N., Lewis, G., Freemantle, N., Johnson, S ...
BMC Psychiatry 22 (185), 2022
232022
Electrophysiological correlates of spontaneous mind wandering in attention deficit/hyperactivity disorder.
G Bozhilova, N., Cooper, R.E., Kuntsi, J., Asherson, P., Michelini
Behavioural Brain Research, 2020
212020
Opinion Piece: The case for establishing a minimal medication alternative for psychosis and schizophrenia
R Cooper, J Mason, T Calton, J Richardson, J Moncrieff
Psychosis, 2021
182021
Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial …
J Moncrieff, N Crellin, J Stansfeld, R Cooper, L Marston, N Freemantle, ...
The Lancet Psychiatry 10 (11), 848-859, 2023
162023
The effect of methylphenidate on very low frequency electroencephalography oscillations in adult ADHD
RE Cooper, C Skirrow, C Tye, G McLoughlin, F Rijsdijk, T Banaschweski, ...
Brain and cognition 86, 82-89, 2014
142014
The costs incurred by the NHS in England due to the unnecessary prescribing of dependency-forming medications
J Davies, RE Cooper, J Moncrieff, L Montagu, T Rae, M Parhi
Addictive Behaviors 125, 107143, 2022
112022
The case for including antipsychotics in the UK NICE guideline: “Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults”
RE Cooper, LM Grunwald, M Horowitz
Psychosis, 2020
92020
Experiences of reduction and discontinuation of antipsychotics: a qualitative investigation within the RADAR trial
JM Nicola Morant, Maria Long, Sandra Jayacodi, Ruth Cooper, Johura Akther ...
eClinicalMedicine, 2023
82023
系统目前无法执行此操作,请稍后再试。
文章 1–20